showed a trendp =0.053
Notably, estriol use during radiotherapy showed a trend toward reducing subjective vaginal dryness (r=–0.297, p =0.053), highlighting its potential role in mitigating vaginal toxicity.
Notably, estriol use during radiotherapy showed a trend toward reducing subjective vaginal dryness (r=–0.297, p =0.053), highlighting its potential role in mitigating vaginal toxicity.